Synthesis and biological evaluation of dihydropyrano-[2,3-c]pyrazoles as a new class of PPARγ partial agonists
Peroxisome proliferator-activated receptor γ (PPARγ) is a well-known target for thiazolidinedione antidiabetic drugs. In this paper, we present the synthesis and biological evaluation of a series of dihydropyrano[2,3-c]pyrazole derivatives as a novel family of PPARγ partial agonists. Two analogues w...
Saved in:
Main Authors: | Qvortrup, Katrine, Jensen, Jakob F., Sørensen, Mikael S., Kouskoumvekaki, Irene, Petersen, Rasmus K., Taboureau, Olivier, Kristiansen, Karsten, Nielsen, Thomas Eiland |
---|---|
Other Authors: | Cavalli, Andrea |
Format: | Article |
Language: | English |
Published: |
2017
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/83481 http://hdl.handle.net/10220/42642 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
Synthetic and natural Peroxisome Proliferator-Activated Receptor (PPAR) agonists as candidates for the therapy of the metabolic syndrome
by: Tan, Chek Kun, et al.
Published: (2017) -
Dual PPARα/γ agonist saroglitazar improves liver histopathology and biochemistry in experimental NASH models
by: Jain, Mukul R., et al.
Published: (2019) -
Inhaled β2-adrenergic agonists in asthma: The evolving dilemma
by: Hui, K.P.
Published: (2014) -
Inhaled β2-adrenergic agonists in asthma: The evolving dilemma
by: Hui, K.P.
Published: (2016) -
Effects of adenosine receptor agonists on nitric oxide release in mouse during endotoxemia
by: Wei, M.H., et al.
Published: (2011)